This compound is primarily utilized in pharmaceutical research and development due to its structural properties, which make it a valuable intermediate in the synthesis of various bioactive molecules. Its piperidine core and trifluoromethylphenyl group are particularly significant in designing compounds targeting neurological disorders, such as antidepressants, antipsychotics, and anxiolytics. The trifluoromethyl group enhances the molecule's metabolic stability and binding affinity to biological targets, making it a key component in drug discovery. Additionally, it is explored for its potential in creating selective enzyme inhibitors and receptor modulators, contributing to the development of novel therapeutic agents. Its application extends to preclinical studies, where it is used to evaluate pharmacokinetic and pharmacodynamic properties of new drug candidates.